Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06186700
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-15
First Post:
2023-12-16
Brief Title:
Effect of Pentoxifylline on Preventing Chemotherapy-induced Mucositis in Patients With Breast Cancer
Sponsor:
Mansoura University
Organization:
Mansoura University
Study Overview
Official Title:
Effect of Pentoxifylline on Preventing Chemotherapy-induced Mucositis in Patients With Breast Cancer
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial is a randomized controlled trial that aims to assess the usefulness of adding pentoxifylline to the neoadjuvant chemotherapy treatment protocol of doxorubicincyclophosphamide for breast cancer patients to decrease the incidence of developing oral mucositis downgrade the mucositis symptoms alleviate the associated pain using the visual analogue scale and enhance the quality of patient life using the EQ-5D-3L questionnaire The participant will administer Pentoxifylline oral tablets three times per day along with the treatment protocol starting from the first doxorubicincyclophosphamide cycle till the end of the fourth cycle The researchers will compare the mucositis incidence and grade in the presence or absence of oral pentoxifylline
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None